Maxion Therapeutics
PrivateLast Round
Series A
Mar 17, 2025
Total Funding Raised
$90.5M
Momentum Score
50 /100
Company Overview
Maxion Therapeutics is a biotechnology company developing antibody-based KnotBody® drugs for ion channel and G protein-coupled receptor (GPCR) driven diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Clinical Trials, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Maxion Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Maxion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 17, 2025 | ||||
| Grant | Apr 19, 2023 | ||||
| Seed | Feb 15, 2023 |
Key People
Founding team and executive leadership
Maxion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| BGF | Series A, Seed |
| British Patient Capital | Series A |
| Monograph Capital | Series A, Seed |
| General Catalyst | Series A |
| British Patient Capital | Series A |
| Solasta Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Joel Edwards appointed as new Chief Business Officer.
- Aug 27, 2025
Dr. Santiago Arroyo appointed as Non-Executive Director.
Maxion Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Maxion Therapeutics's valuation, stock price, and market status.
